These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 15123398
1. Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part I: what do I tell my patients? Moyad MA. Urol Clin North Am; 2004 May; 31(2):195-8. PubMed ID: 15123398 [Abstract] [Full Text] [Related]
2. Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part II: what do I tell my patients? Moyad MA. Urol Clin North Am; 2004 May; 31(2):199-205. PubMed ID: 15123399 [Abstract] [Full Text] [Related]
3. Improving overall men's health and potentially reducing the risk of certain cancers via serum markers and risk assessment for coronary heart disease. Moyad MA. Urol Oncol; 2004 May; 22(6):485-9. PubMed ID: 15610866 [Abstract] [Full Text] [Related]
5. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men. Nasir K, Santos RD, Roguin A, Carvalho JA, Meneghello R, Blumenthal RS. Int J Cardiol; 2006 Mar 22; 108(1):68-75. PubMed ID: 16516700 [Abstract] [Full Text] [Related]
6. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S. Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227 [Abstract] [Full Text] [Related]
7. Search for an optimal atherogenic lipid risk profile: from the Framingham Study. Nam BH, Kannel WB, D'Agostino RB. Am J Cardiol; 2006 Feb 01; 97(3):372-5. PubMed ID: 16442398 [Abstract] [Full Text] [Related]
8. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents. Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH. Am J Cardiol; 2006 Nov 01; 98(9):1231-3. PubMed ID: 17056335 [Abstract] [Full Text] [Related]
9. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study. Sritara P, Patoomanunt P, Woodward M, Narksawat K, Tulyadachanon S, Ratanachaiwong W, Sritara C, Barzi F, Yamwong S, Tanomsup S. Angiology; 2006 Nov 01; 58(6):757-63. PubMed ID: 18216384 [Abstract] [Full Text] [Related]
10. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C, European Consensus Panel on HDL-C. Curr Med Res Opin; 2004 Aug 01; 20(8):1253-68. PubMed ID: 15324528 [Abstract] [Full Text] [Related]
11. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH. Am J Cardiol; 2007 Nov 15; 100(10):1499-501. PubMed ID: 17996508 [Abstract] [Full Text] [Related]
12. Depressive symptoms and serum lipid fractions in middle-aged men: physiologic and health behavior links. Igna CV, Julkunen J, Vanhanen H, Keskivaara P, Verkasalo M. Psychosom Med; 2008 Nov 15; 70(9):960-6. PubMed ID: 18981271 [Abstract] [Full Text] [Related]
13. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW, L-TAP 2 Investigators. Am Heart J; 2009 Nov 15; 158(5):860-6. PubMed ID: 19853709 [Abstract] [Full Text] [Related]
14. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information? Holcombe SM, Brubaker PH. J Cardiopulm Rehabil Prev; 2007 Nov 15; 27(6):386-9. PubMed ID: 18197073 [Abstract] [Full Text] [Related]
15. Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease. Tonstad S, Sundfør T, Seljeflot I. Am J Cardiol; 2005 May 15; 95(10):1187-91. PubMed ID: 15877991 [Abstract] [Full Text] [Related]
16. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Rothenbacher D, Brenner H, März W, Koenig W. Eur Heart J; 2005 Aug 15; 26(16):1640-6. PubMed ID: 15932907 [Abstract] [Full Text] [Related]
17. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D, TASPIC-CRO Study Group Investigators. Eur J Cardiovasc Prev Rehabil; 2006 Aug 15; 13(4):646-54. PubMed ID: 16874158 [Abstract] [Full Text] [Related]
19. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Ko M, Kim MT, Nam JJ. Int J Cardiol; 2006 Jun 16; 110(2):184-90. PubMed ID: 16412525 [Abstract] [Full Text] [Related]
20. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Eur J Cardiovasc Prev Rehabil; 2006 Aug 16; 13(4):571-7. PubMed ID: 16874147 [Abstract] [Full Text] [Related] Page: [Next] [New Search]